Latest Post

June 21, 2021

Control Strategy: What, When, Where and Why for Drug-Device Combination Products

There are clear gaps in understanding in the market of combination products. A major one was highlighted at a recent workshop sponsored by West. A survey showed that <em>over 20% of attendees were not aware of the considerations needed to build a control strategy. </em>
Fran DeGrazio

Fran DeGrazio

Chief Scientific Officer

Categories

Search the Blog

Archive

{1}

{2}
{3}

{4}

  • Previous Posts
    CZ Syringe and Vial with patient and nurse

    December 28, 2020

    Particles in Injectable Drugs

    Lynn Yao

    Lynn Yao

    Manager, Scientific Affairs, CN

    Integrated Solutions Program Graph

    September 11, 2020

    Introducing West’s New Interactive Integrated Solutions Webpage

    Shari Krusniak

    Shari Krusniak

    Director, Marketing, Contract Manufacturing & Integrated Solutions

    AFM topography and modulus mapping image

    April 10, 2020

    Not All Barriers Are Created Equal

    Cathy Zhao

    Cathy Zhao

    Director, Scientific Insights Lab

    SmartDose, Elastomers, Seals and Syringe plungers

    September 11, 2018

    Supporting Patient Safety – Contribution By Drug Containment Solutions

    Heike Kofler

    Heike Kofler, Ph.D.

    Manager, Technical Customer Support

    Envision Verification Process

    July 16, 2018

    Three Questions to Ask to Improve Your Injectable Drug Packaging Process

    Bill Matakas

    Bill Matakas

    Senior Director, Product Management & Marketing Operations

    Daikyo Crystal Zentih Leur Lock Syringe

    May 01, 2018

    Addressing the Complexities of Ophthalmic Drug Delivery

    Susan Dounce

    Susan Dounce

    Principal SME, Prefilled Syringes, Crystal Zenith, Combination Products

    Load more